Cambridge Experimental Cancer Medicine Centre (Cambridge ECMC)

United Kingdom (UK)

1 December 2019 - 30 November 2020

Region: Global
Subject/journal group: All

The table to the right includes counts of all research outputs for Cambridge Experimental Cancer Medicine Centre (Cambridge ECMC) published between 1 December 2019 - 30 November 2020 which are tracked by the Nature Index.

Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.

Research collaboration: Cambridge Experimental Cancer Medicine Centre (Cambridge ECMC) is a research collaboration whose article contributions are accrued to its participating partner institutions.

Note: Articles may be assigned to more than one subject area.

Count Share
22 0.55

Outputs by subject (Share)

Subject Count Share
Life Sciences 20 0.50
American Journal of Human Genetics 1 0.01
Immunity 1 0.01
Journal of Biological Chemistry 1 0.20
Journal of Clinical Investigation 1 0
Nature 3 0.01
Nature Communications 5 0.01
Nature Genetics 2 0.02
Neuron 1 0.05
Science Translational Medicine 1 0.06
eLife 4 0.13
Physical Sciences 3 0.05
Chemistry 1 0.01

1 December 2019 - 30 November 2020

International vs. domestic collaboration by Share

  • 46.85% Domestic
  • 53.15% International

Note: Hover over the graph to view the percentage of collaboration.

Top 10 domestic collaborators by Share (92 total)

  • Cambridge Experimental Cancer Medicine Centre (Cambridge ECMC), United Kingdom (UK)
  • Domestic institution
  1. University of Leeds, United Kingdom (UK) (4.39)
    0.53
    3.86
  2. St James's University Hospital, United Kingdom (UK) (1.43)
    0.53
    0.89
  3. Leeds Teaching Hospitals NHS Trust (LTHT), United Kingdom (UK) (0.98)
    0.53
    0.45
  4. The University of Manchester (UoM), United Kingdom (UK) (0.69)
    0.03
    0.66
  5. Genomics England Ltd., United Kingdom (UK) (0.65)
    0.01
    0.64
  6. Newcastle University, United Kingdom (UK) (0.60)
    0.01
    0.58
  7. Heriot-Watt University, United Kingdom (UK) (0.40)
    0.01
    0.39
  8. University of Glasgow, United Kingdom (UK) (0.39)
    0.07
    0.32
  9. University of Oxford, United Kingdom (UK) (0.30)
    0.05
    0.25
  10. Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM), United Kingdom (UK) (0.24)
    0.01
    0.23

Top 10 international collaborators by Share (567 total)

  • Cambridge Experimental Cancer Medicine Centre (Cambridge ECMC), United Kingdom (UK)
  • Foreign institution
  1. Agency for Science, Technology and Research (A*STAR), Singapore (0.74)
    0.01
    0.74
  2. National University of Singapore (NUS), Singapore (0.55)
    0.01
    0.55
  3. Duke-National University of Singapore (Duke-NUS), Singapore (0.45)
    0.01
    0.44
  4. Harvard University, United States of America (USA) (0.40)
    0.07
    0.33
  5. National Institutes of Health (NIH), United States of America (USA) (0.35)
    0.02
    0.33
  6. Catholic University of Leuven (KU Leuven), Belgium (0.29)
    0.06
    0.22
  7. University of Rome Tor Vergata, Italy (0.28)
    0.01
    0.27
  8. University of California, San Diego (UC San Diego), United States of America (USA) (0.26)
    0.05
    0.21
  9. Radboud University Nijmegen (RU), Netherlands (0.26)
    0.01
    0.25
  10. Helmholtz Association of German Research Centres, Germany (0.26)
    0.02
    0.24

Note: Collaboration is determined by the fractional count (Share), which is listed in parentheses.

Cambridge Experimental Cancer Medicine Centre (Cambridge ECMC)

Participating institutions

Cambridge Experimental Cancer Medicine Centre (Cambridge ECMC) is a research collaboration whose article contributions are accrued to its participating partner institutions below.

Affiliated joint institutions and consortia

Creative Commons License

Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Return to institution outputs

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER